ISHLT transplantation guidelinesListing Criteria for Heart Transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006
Section snippets
1. Evaluation of listing criteria for cardiac transplantation
Two of the previous International Society for Heart and Lung Transplantation (ISHLT) consensus conferences have addressed listing criteria for patients awaiting heart transplantation.1, 2 Guidelines from these two conferences were completed before the acceptance of β-blocker and device therapies in the clinical treatment of late-stage heart failure. Guidelines addressing the management of heart failure are now available from the European Society of Cardiology (ESC) as well as the American
References (128)
- et al.
24th Bethesda Conference: Cardiac transplantationTask Force 3: Recipient guidelines/prioritization
J Am Coll Cardiol
(1993) - et al.
Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure
J Am Coll Cardiol
(2002) - et al.
Impact of beta-blocker therapy on functional capacity criteria for heart transplant listing
J Heart Lung Transplant
(2003) - et al.
Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers
J Heart Lung Transplant
(2003) - et al.
Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy
Am J Cardiol
(2003) - et al.
Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure
J Am Coll Cardiol
(1997) - et al.
Comparison of ventilatory expired gas parameters used to predict hospitalization in patients with heart failure
Am Heart J
(2002) - et al.
Peak Vo2 and Ve/Vco2 slope in patients with heart failure: a prognostic comparison
Am Heart J
(2004) - et al.
Exercise hyperventilation chronic congestive heart failure, and its relation to functional capacity and hemodynamics
Am J Cardiol
(1992) - et al.
Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy
J Am Coll Cardiol
(1996)
The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure
J Am Coll Cardiol
(2000)
Improvement in exercise capacity of candidates awaiting heart transplantation
J Am Coll Cardiol
(1995)
Serial exercise testing and prognosis in selected patients considered for cardiac transplantation
Am Heart J
(1998)
Selection of patients for heart transplantation in the current era of heart failure therapy
J Am Coll Cardiol
(2004)
The effect of beta-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure
J Heart Lung Transplant
(2003)
Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers
J Heart Lung Transplant
(2004)
Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure
Am J Cardiol
(2005)
Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure
J Am Coll Cardiol
(2001)
Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure
J Heart Lung Transplant
(2004)
Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: the EPICAL study
Am Heart J
(2000)
Mortality remains high for outpatient transplant candidates with prolonged (>6 months) waiting list time
J Am Coll Cardiol
(1999)
Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens
J Am Coll Cardiol
(1991)
Serial versus isolated assessment of clinical and instrumental parameters in heart failure: prognostic and therapeutic implications
Am Heart J
(2003)
The evolving management of acute right-sided heart failure in cardiac transplant recipients
J Am Coll Cardiol
(2001)
Pretransplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation
J Heart Lung Transplant
(2005)
Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group
J Am Coll Cardiol
(1992)
Recipient selection in cardiac transplantation: contraindications and risk factors for mortality
J Heart Lung Transplant
(2002)
Use of two recipient lists for adults requiring heart transplantation
J Thorac Cardiovasc Surg
(2003)
Heart transplantation in patients seventy years of age and older: a comparative analysis of outcome
J Thorac Cardiovasc Surg
(2001)
Long-term results of heart transplantation in patients older than 60 years
J Thorac Cardiovasc Surg
(2003)
Differential characteristics of heart transplantation in patients older than 60 years
Transplant Proc
(2003)
The registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report—2003
J Heart Lung Transplant
(2003)
An analysis of the effect of age on survival after heart transplant
J Heart Lung Transplant
(1999)
Nothing is fair or good alone
J Thorac Cardiovasc Surg
(2003)
The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report—2004
J Heart Lung Transplant
(2004)
Effect of obesity on outcome after cardiac transplantation
Transplant Proc
(1999)
Results of heart transplantation in patients with preexisting malignancies
Am J Cardiol
(1997)
Pretransplant malignancy in candidates and posttransplant malignancy in recipients of cardiac transplantation
Ann Oncol
(1996)
Heart transplantation in chemotherapeutic dilated cardiomyopathy
Transplant Proc
(2003)
Cardiac transplantation in patients with preexisting neoplastic diseases
Am J Cardiol
(1990)
Factors predicting 10-year survival after heart transplantation
J Heart Lung Transplant
(2005)
Heart transplantation in diabetic recipients: a decade review of 161 patients at Columbia Presbyterian
J Thorac Cardiovasc Surg
(2004)
Combined heart and kidney transplantation with allografts from the same donor
Ann Thorac Surg
(1994)
Recrudescent tobacco exposure following heart transplantation: clinical profiles and relationship with athero-thrombosis risk markers
Am J Transplant
(2005)
Risk factors for smoking abuse after heart transplantation
Transplant Proc
(2004)
Listing criteria for cardiac transplantation: results of an American Society of Transplant Physicians–National Institutes of Health Conference
Transplantation
(1998)
Selection and treatment of candidates for heart transplantationA statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association
Circulation
(1995)
Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure
Circulation
(1991)
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
Lancet
(1999)
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
Lancet
(1999)
Cited by (806)
2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee
2024, Journal of the American College of CardiologyReversibility of precapillary pulmonary hypertension and outcomes after heart transplantation bridged with left ventricular assist devices: Insight from the United Network for Organ Sharing
2024, Journal of Thoracic and Cardiovascular SurgeryHeart Transplantation—Postoperative Considerations
2024, Critical Care ClinicsLeft Ventricular Assist Device and the Current State of the Art: HeartMate 3 at 5 Years
2024, Heart Failure ClinicsHigh-Risk Pulmonary Hypertension Does Not Worsen Outcomes in Heart Transplantation
2023, American Journal of CardiologyImpact of preheart transplant spirometry and DCLO measurement on post-transplant pulmonary outcomes
2023, Journal of Heart and Lung Transplantation
Reprint requests: Amanda Rowe, Executive Director, ISHLT, 14673 Midway Road, Suite 200, Addison, TX 75001. E-mail: [email protected]
Copyright © 2006 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.